BTIG analyst Thomas Shrader lowered the firm’s price target on Denali Therapeutics (DNLI) to $32 from $35 and keeps a Buy rating on the shares after the company announced topline data from the Phase 2 ...

BTIG analyst Ryan Zimmerman maintained a Buy rating on Stryker (SYK – Research Report) yesterday and set a price target of $394.00. The ...

BTIG analyst Ryan Zimmerman maintained a Buy rating on Penumbra (PEN – Research Report) yesterday and set a price target of $270.00. The ...

Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Get Free Report) has earned a consensus recommendation of “Hold” from the twenty ...

Upwork (NASDAQ:UPWK – Get Free Report) had its target price lifted by stock analysts at Jefferies Financial Group from $19.00 to $20.00 in a research note issued to investors on Monday,Benzinga ...

Fintel reports that on January 7, 2025, BTIG initiated coverage of Hims & Hers Health (NYSE:HIMS) with a Buy recommendation.

BTIG Research has recently reduced Fiverr International Ltd (FVRR) stock to Neutral rating, as announced on November 4, 2024, according to Finviz. Earlier, on July 2, 2024, UBS had reduced the stock ...

Short seller Hindenburg Research accused Carvana of accounting manipulation and unstable loans. The company denies the ...

Here are four large-cap value stocks that growth and income investors may want to consider now. History suggests they will ...

BTIG maintains a “Buy” rating for Carvana Co. (NYSE:CVNA) with a stock price of $185.5. Carvana amends its agreement with ...

The industry should save on interest expenses this year as it follows the Fed's lead in cutting rates. The downside is that ...

Hindenburg Research's report on Carvana causes its shares to drop 11% amid accusations of poor practices and financial ...